Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
CYP2A6 Gene	NCIT_C48629	[This gene plays a role in the oxidation of nicotine to its carcinogenic metabolites.]
Stage IA Vaginal Cancer AJCC v8	NCIT_C139659	[Stage IA includes: T1a, N0, M0. T1a: Tumor confined to the vagina, measuring 2.0 cm or less. N0: No regional lymph node metastasis. M0: No distant metastasis. (AJCC 8th Ed.)]
Dosage Form Not Applicable	NCIT_C48624	[An indication that the dosage form is not relevant or appropriate.]
Neoplastic Parathyroid Gland Water-Clear Cell	NCIT_C48625
Neoplastic Parathyroid Gland Clear Cell	NCIT_C48279
Vaginal Cancer pNX TNM Finding v8	NCIT_C139653	[Vaginal cancer in which the regional lymph nodes cannot be assessed. (from AJCC 8th Ed.)]
Package Type Not Stated	NCIT_C48626	[The package type is not stated or is unavailable.]
Vaginal Cancer pN0 TNM Finding v8	NCIT_C139654	[Vaginal cancer with no regional lymph node metastasis. (from AJCC 8th Ed.)]
McCune-Albright Syndrome	NCIT_C48627	[A syndrome characterized by the presence of polyostotic fibrous dysplasia, cafe-au-lait skin lesions, and sexual precocity. It is caused by mutations within the GNAS genetic locus.]
Vaginal Cancer pN0(i+) TNM Finding v8	NCIT_C139655	[Vaginal cancer with isolated tumor cells in regional lymph node(s) no greater than 0.2 mm. (from AJCC 8th Ed.)]
gp100:614-622 Peptide	NCIT_C48631	[A synthetic peptide consisting of amino acid residues 614 through 622 of the melanoma-melanocyte antigen glycoprotein 100 (gp100). Vaccination with gp100:614-622 peptide may stimulate a cytotoxic T-cell immune response against tumor cells that express this antigen, resulting in decreased tumor growth and cell lysis. gp100 antigen is a self-antigen expressed by melanocytes, pigmented retinal cells and most melanoma lesions and recognized via class I and II HLA-restricted mechanisms.]
MAGE-3.A1 Peptide Vaccine	NCIT_C48632	[A synthetic peptide cancer vaccine consisting of human leukocyte antigen HLA-A1-restricted peptide derived from human melanoma antigen 3 (MAGE-3) with potential immunostimulating and antineoplastic activities. Upon administration, MAGE-3.A1 peptide vaccine may stimulate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing MAGE-3, resulting in tumor cell lysis. MAGE-3, a tumor-associated antigen (TAA), is overexpressed by a variety of cancer cell types.]
HLA-B44-Restricted MAGE-3 Peptide	NCIT_C48633	[A peptide comprised of the synthetic human leukocyte antigen (HLA)-B44-binding peptides derived from amino acid sequences of MAGE-3 with potential antitumor activity. Vaccination with HLA-B44-restricted MAGE-3 peptide may elicit a cytotoxic T lymphocyte immune response against tumor cells expressing MAGE-3. MAGE-3 is an antigen found on many tumor cell types, including melanoma and lung, prostate, colon, thyroid, and breast cancers.]
SPL Business Operation Terminology	NCIT_C73600	[Terminology used for representation of the information on business operations concerned with medical product development, manufacturing, and marketing in the framework of the Structured Product Labeling documents.]
Vaginal Cancer pT4 TNM Finding v8	NCIT_C139650	[Vaginal cancer with tumor invading the mucosa of the bladder or rectum and/or extending beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4). (from AJCC 8th Ed.)]
HLA-B44-Restricted Tyrosinase Peptide	NCIT_C48634	[A synthetic peptide consisting of synthetic human leukocyte antigen (HLA)-B44-binding peptides derived from amino acid sequences of the melanoma-associated enzyme tyrosinase with potential antitumor activity. Vaccination with HLA-B44-restricted tyrosinase peptide may stimulate cytotoxic T lymphocyte response against tyrosinase-expressing tumor cells, resulting in decreased tumor growth and cell lysis.]
Hexaminolevulinate Hydrochloride	NCIT_C73601	[The hydrochloride salt form of hexaminolevulinate, a hexyl ester of the heme precursor 5-aminolevulinic acid (ALA) with potential photosensitizing activity. Hexaminolevulinate serves as a precursor of photoactive porphyrins (PAPs), particularly protoporphyrin IX (PpIX), which selectively accumulate in rapidly proliferating cells, such as those seen in tumor tissue. When exposed to blue light, PAPs are activated and emit red light thereby allowing tumor imaging.]
Alpha-glucosidase Inhibitor	NCIT_C139651	[Any agent that inhibits the enzyme alpha-glucosidase located in the intestines. This prevents the breakdown of complex carbohydrates to glucose and other monosaccharides, which results in decreased intestinal absorption of monosaccharides.]
Glucosidase Inhibitor	NCIT_C2846	[Any substance that inhibits glucosidase, specifically alpha-glucosidase in the brush border of the small intestines, an enzyme that catalyzes the breakdown of carbohydrates to simple sugars. Inhibition of glucosidase reduces and delays the effects of ingested carbohydrates on blood sugar.]
How Big a Problem is Weak Urine Stream or Incomplete Emptying	NCIT_C125019	[A question about an individual's assessment of how big a problem a weak urine stream or incompletely emptying has been.]